Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy
NCT02798757
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Diabetes
Interventions
DRUG:
Dapagliflozin
Sponsor
University of Ioannina